Gritstone Oncology CEO on leveraging cancer drug development for coronavirus vaccine - Vdieo
Gritstone Oncology CEO Andrew Allen explained how the nascent cancer drug developer caught the attention of the Gates Foundation in developing a potential coronavirus vaccine to slow the emergence of Covid-19 variants. Subscribe to CNBC PRO for access to investor and analyst insights: https://cnb.cx/2Vtntx6
-
Most popular related searches
Customer comments
No comments were found for Gritstone Oncology CEO on leveraging cancer drug development for coronavirus vaccine - Vdieo. Be the first to comment!